Li Zheng¹, Zhen Qiang Gao² and Shu Xian Wang^3
1Department of Pharmacology, National Institutes Pharmaceutical Research and Development, Beijing 102206, China
²Department of Pathology, Beijing Medical University, Beijing 100083, China
³National Administrative Center of New Drug Research, Beijing 10081 0, China
Li Zheng, male, born on 1965-09-01 in Hubei Province, graduated from China Pharmaceutical University, now associate professor of gastroenterology, ha ving 14 papers published.
Supported by the National “Eighth Five-Year Plan” Program, No. 85-922-01.
Correspondence to: Li Zheng, National Institutes Pharmaceutical Research and Development, Beijing 102206, China
Telephone: +86-10-69732071, Fax. +86-10-69731050
Email. nipzl＠263.net or zwl＠cenpok.net
Received: 1999-08-11 Accepted: 1999-10-22

Subject headings: colitis, ulcerative; disease model, animal; rats

Zheng L, Gao ZQ, Wang SX. A chronic ulcerative colitis model in rats. World J Gastroentero, 2000;6(1):150-152

INTRODUCTION
In recent years, there have been many reports about animal model to investigate drugs for inflammatory bowel diseases (IBD). The experimental animal model often used is acetic acid-induced damage of colonic muscosa. In the present study, this animal model was investigated by administering various concentrations of TNBS.

MATERIALS AND METHODS
Materials
Animals Wistar male and female rats weighing 258g±25 g were used in this study. They were provided by the Department of Experimenta l Animals of Beijing Medical University. They were housed in rack-mounted cages with a maximum of 6 rats, and were fasted for 12h with access to water ad libitum before experiment.

Reagent Fifty mmol/L (pH=6.0) phosphate buffer. 0.5 % hexadecyltrimethylammonium bromide (HTAB, Beijing Xizhong Chemical Plant) in 50mmol/L (pH=6.0) phosphate buffer, 50mmol/L (pH=6.0) phosphat e buffer containing 16.7% (g/L) o-dianisidine Dihydrochloride (Sigma chemical Co.) and 0.0005% hydrogen peroxide, TNBS (Sigma chemical Co. 5% w/v solution) solution of 30% ethanol, 20% (w/v) ethyl carbarnate in 0.9% saline.

Instrument T25 Ultra-tukrax (German, JANKE & KUNKEL IKA-Labortechnik). 4710 series Ultrasonic homogenizer (Cole-Parmer Inst rument Co. America), GL20A Refrigerated Centrifuge (Hunan Instrument and Meter Plant China), UV-260 Spectrophometer (Shimuduzu Co. Japan), PHSJ-4 pH meter (Shanghai Leici Instrument Plant China), Libror EB-2080M Lectronic Animal Balance (Shimuduzu Co. Japan).

Methods
Effect of various TNBS doses on myeloperoxidase (MPO) activity, colon da mage and weight A total of 30 rats were randomized into five groups, 6 rats each group (in a cage), consisting of a 30% ethanol control group as well as four dose TNBS groups. The animals were anesthetized with 20% ethyl carbarnat e (ip, 6mL/kg), and 0.5mL of either 30% ethanol (controls) or var ious concentrations of TNBS was slowly administered into the lumen of the colon via the anus using a rubber catheter (12cm long, external diameter 2mm ). The rats were killed after 3wk, and the distal colon (8cm) was removed, opened longitudinally and washed to remove lumina contents, colon wet weight was weighed, and colonic injuries were evaluated.The excised colon was pinned out on a wax block washed with 0.9% saline and assigned a code number. The colon was immediately examined under a stereomicroscope and any visible damage was scored on a 0-5 scale (Table 1). Small sections of colon were taken from two distinct areas from each colon and placed in 10% formalin for histological examination. The colon was fixed, cut longitudinally i nto 5μm sections, stained with hematoxylin and eosin. The second segment (200mg-400mg) was immediately frozen for subsequent estimation of MPO activity^［1］.

Table 1 Criteria for scoring the gross morphologic damage

The relationship of MPO and time-course Based on the results of dose-response studies, the dose of TNBS used in subsequent experiments was 100mg/kg per rat. A total of 40 rats (5 rats per cage) administered a single intracolonic dose of TNBS ethanol solution (0.5mL/rat). In control experiments, 5 rats received 0.5mL 30% ethanol. At various times (24 h and 1wk-8wk) after intracolonic administration of TNBS or one of the control solutions, 5 rats from each treatment group were randomly selected and killed, the colon tissue MPO activity was determined as the indices of inf lammation.

Statistical analysis The data were expressed as mean±SD, and analyzed using the Student′s t test to compare the difference.

RESULTS
Assessment of MPO activity, colonic weight and damage score
The severity of colonic damage induced by TNBS increased with the dose (Figure 1). Rats that received the lowest dose of TNBS (25mg/kg) had damage score s, colon weights and tissue levels of MPO activity were not significantly differ ent from the control animals treated only with 30% ethanol vehicle (P＞0. 05). When doses of TNBS (50mg/kg-150mg/kg) were used, the dama ge scores, colon weights and tissue levels of MPO activity increased in a dose-related manner and there was a significant difference compared with control (30% ethanol).

Histological examination
Three weeks after TNBS/ethanol administration, the bowel wall was basically no rmal in the 25mg/kg group, and “string of beads” was found in 1 rat. M edium hemorrhage, edema and ulcers, cryptoabscess in the mucosa were observed in animals that received 50mg/kg of TNBS, in TNBS group (100mg/kg) , the bowel lumen became narrow with thickened wall (2mm-3mm), on th e bowel lumen mucosal surface area there was adherent membrane with brown black, liner ulcers (1mm-6mm), proliferous lymphocyte tissue, inflammatory granulomas and submucosal neutrophils infiltration. Macrophages, lymphocytes, fibroblasts, and cryptoabscess were also observed. The TNBS (150mg/kg) group had noticeable ulcers and inflammatory granulomas in their colon, neutrophil infiltration was obviously observed in mucosa and sub mucosa extensive necrosis of the colonic mucosa and exfoliation of the epithelia were found in other rats with intact muscularis. In cases of severe ulcers, the colon had often adhered to surrounding intestinal tissues and abdominal wall (Figure 2).

Time-course study
A single instillation of TNBS at the dose of 100mg/kg into the rat colon produced chronic ulcers and inflammation which had persisted for up to 7wk. MPO activity reached a maximum value at 3wk after TNBS, and was follow ed by a gradual reduction in activity. At 3wk the MPO value was at near ba seline level (Figure 3).

DISCUSSION
TNBS is a hapten, when it is bound with a substance of high molecular tissue proteins, it will turn into a antigen. It has been shown that it can elicit immunologic responses, induce generation of colitis^［2,3］. The histological features of the animals received TNBS (50mg/kg-150mg/kg) were chronic inflammation, relatively long duration of inflammation and changes in various inflammatory mediators such as prostaglandin E₂, thromboxane B₂, leukotriene B₄, 6-keto-prostaglandin F_1α, leukotriene C₄, plet elet-activating factor and interleukin. This model is characterized by the simple process and reproducible colonic damage, inexpensive and short duration of the experiment, long-lasting damage with inflammatory cell infiltration and ulcers. Thus, the model is rather suitab le for the assessment of the effects of potential agents. In the present study, the dose of TNBS producing a moderate colonic inflammation and ulcers was about 100mg/kg, the severity of colonic inflammation induced by TNBS increased with the dose administered. So a TNBS dose of 100mg/kg was chosen for a n appropriate experimental dose, the results were similar to the reports in the literature^［4,5］.
      There was extensive colonic muscosal and submuscosal damage characterized by infiltration of inflammatory cells and ulcers after different doses of TNBS (50mg/kg-150mg/kg) were administered into the colons of rats. After the animals received TNBS (100mg/kg), in acute phase, extensive infiltratio n of inflammatory cells constituted the main part; in chronic phase, the inflamm atory granulomas and ulcers induced by TNBS made up the main part. MPO is an enz yme found in the neutrophils, and can be used as a quantitative index of inflamm ation in colonic tissue^［1］. MPO activity may be regarded as an index of inflammation damage^［6］.

Figure 1(PDF) Rats were killed 3wk after intracolon ic administration of 25mg/kg-150mg/kg of TNBS. Colonic damage, colon weight and tissue MPO activity were assayed. Data of TNBS-treated rats were compared with control (30% ethanol) group by Student′s t test, ^aP＜0.05, ^bP＜0.01.
Figure 2 Histological findings in ulcerative colitis induced by different doses of TNBS ethanol.
a: TNBS 25mg/kg, the mucosa is normal.\ 
b: TNBS 50g/kg, small mucosal ulc ers and cryptoabscess formation.\ 
c-
d: TNBS 100mg/kg, mucosal ulcers, in flammatory exudate, proliferous granulomas and cells infiltration.\ 
e-
f: TNBS 15 0g/kg, gross ulcers and proliferous granulomas, necrosis of epithelium at mu cosal sueface and inflammatory cell infiltration (He, ×100)
Figure 3(PDF)The effects of intracolonic administration of 100mg/kg of TNBS on MPO activity 1wk-8wk after administra tion. Each bar represents the mean±SD of 5 animals. All data for TNBS tr eated rats were compared with 0wk (control group). ^aP＜0.05, ^bP＜0.01.

REFERENCES
1    Zheng L, Wang SX, Cui DY, Cui YY. A simple method of assessing inflammatory bowel disease. Zhongguo Yaolixue 
      Tongbao,1996;12:468-469
2    Little JR, Eisen HN. Preparation and characterization of antibodies specific for the 2, 4, 6 trinitrophenyl group.
      Biochemistry,1966;5:3385-3395
3    Fidler JM. Induction of hapten-specific immunological tolerance and immunity in B lymphocytes Ⅶ. correlation between
      trinitrobenzenesulfonic acid administration,serum trinitrophenyl content, and level of tolerance.Cell 
      Immunol,1985;94:285-291
4    Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel
      disease.Gastroenterology,1984;86:453-460
5    Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces
      reactive oxygen species.Gastroenterology, 1991;101:540-547
6    Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal in flammation based on myeloperoxidase
      activity.Gastroenterology,1984;87:1344-1350  

Reviews	Add
more>>